Cellectar Biosciences, Inc. 4
4 · Cellectar Biosciences, Inc. · Filed Apr 21, 2016
Insider Transaction Report
Form 4
NEIS JOHN
Director
Transactions
- Purchase
Common Stock, par value $0.00001 per share
2016-04-20$2.12/sh+234,742$497,653→ 297,984 total(indirect: See Footnote) - Purchase
Series A Warrants
2016-04-20$0.01/sh+234,742$2,347→ 274,613 total(indirect: See Footnote)Exercise: $3.04From: 2016-04-20Exp: 2021-04-20→ Common Stock (234,742 underlying)
Footnotes (1)
- [F1]These securities are held by Venture Investors Early Stage fund IV Limited Partnership and Advantage Capital Wisconsin Partners I, Limited Partnership. VIESF IV GP LLC is the general partner of Venture Investors Early Stage Fund IV Limited Partnership and Venture Investors LLC is the submanager and special limited partner of Advantage Capital Wisconsin Partners I, Limited Partnership. The investment decisions of VIESF IV GP LLC and Venture Investors LLC are made collectively by seven managers, including the reporting person. The reporting person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest herein.